Stichting TRICALS Foundation — Sponsor Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

0 Recruiting

2 Completed trials

6 Countries active

1 Unique IMPs

100% Results reported

Phase III

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

Top indications

2 total

Lighthouse II study Ended

2024-517054-94-00 Phase III 5 countries ABACAVIR SULFATE, LAMIVUDINE, DOLUTEGRAVIR SODIUM
Magnet Study Ended

2024-516559-41-00 Phase III 4 countries

Showing 1–2 of 2 trials